Phase III randomized trial of preoperative chemotherapy versus preoperative concurrent chemotherapy and thoracic radiotherapy followed by surgical resection and consolidation chemotherapy in favorable prognosis patients with stage IIIA (N2) non-small cell lung cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Docetaxel; Filgrastim; Pegfilgrastim
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 28 Jun 2013 Biomarkers information updated
- 27 Dec 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 24 Feb 2009 Status changed from active, no longer recruiting to completed, from clinicaltrials.gov record.